Combination of 5-FU, Leucovorin and Cisplatin (CDDP): an efficient low-toxic chemotherapy in advanced gastric adenocarcinoma

M. Ychou; Y. Fedkovic; A. Christopoulou; B. Saint-Aubert; Ph Rouanet; C. Astre; H. Pujol

doi:10.1007/978-2-8178-0765-2_83

Retour

Chapitre d'ouvrage

Combination of 5-FU, Leucovorin and Cisplatin (CDDP): an efficient low-toxic chemotherapy in advanced gastric adenocarcinoma

M. Ychou, Y. Fedkovic, A. Christopoulou, B. Saint-Aubert, Ph Rouanet, C. Astre et H. Pujol

Cancer Treatment An Update, pp.396-398

Springer Paris

1994

DOI: https://doi.org/10.1007/978-2-8178-0765-2_83

Résumé

Advanced Gastric Adenocarcinoma

Advanced Gastric Cancer

Clin Oncol

Gastric Cancer

Metastatic Gastric Cancer

Metastatic gastric cancer remains a frequent disease with spontaneous median survival of about 6 months [1]. FAM regimen (5-FU, Doxorubicin and Mitomycin) was until the nineteens, considered as standard treatment of advanced gastric cancer. Recent publication of EORTC data showed significant improvement of survival in patients treated with FAMTX (5-FU, Methotrexate, Doxorubicin) in comparison to FAM [11].

Indicateurs

1 Consultations de la notice

Détails

Titre: Combination of 5-FU, Leucovorin and Cisplatin (CDDP): an efficient low-toxic chemotherapy in advanced gastric adenocarcinoma
Créateurs - sans rôle: M. Ychou
Y. Fedkovic
A. Christopoulou
B. Saint-Aubert
Ph Rouanet
C. Astre
H. Pujol
Contributeurs - sans rôle: P. Banzet
J. F. Holland
D. Khayat
M. Weil
Détails de publication: Cancer Treatment An Update, pp.396-398
Éditeur: Springer Paris; Paris
Identifiants: 99140152509311
Unité académique: Institut de Recherche en Cancérologie de Montpellier - IRCM
Langue: English
Type de ressource: Book chapter